SeaStar Medical Holding (ICU) EPS (Basic) (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly EPS (Basic) came in at -$0.9 in Q1 2026, up 79.47% YoY from -$0.5 in Q1 2025, and up 35.87% on a QoQ basis from -$1.4 in Q4 2025.
SeaStar Medical Holding (ICU) EPS (Basic) (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of EPS (Basic) data on file, last reported at -$0.9 in Q1 2026.
- Quarterly EPS (Basic) rose 79.47% year-over-year to -$0.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.04 (up 83.54% YoY) and the FY2025 annual result came in at -$5.86, up 91.16% from the prior year.
- EPS (Basic) climbed to -$0.9 in Q1 2026, from -$1.4 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.9 in Q1 2026 to a low of -$255.5 in Q4 2022.
- A 5-year average of -$47.82 and a median of -$21.57 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 646.59% — and 2025, when it surged 90.75%.
- Tracing ICU's EPS (Basic) over 5 years: stood at -$255.5 in 2022, then soared by 57.3% to -$109.1 in 2023, then surged by 89.18% to -$11.8 in 2024, then surged by 88.13% to -$1.4 in 2025, then soared by 35.87% to -$0.9 in 2026.
- The last three EPS (Basic) figures came in at -$0.9 (Q1 2026), -$1.4 (Q4 2025), and -$1.32 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.18 |
| 10 | SeaStar Medical Holding | 13.97 Mn | 6.97 Mn | 561,000.00 | -0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.95 |
| Mar 31, 2026 | -0.90 |
| Dec 31, 2025 | -1.40 |
| Sep 30, 2025 | -1.32 |
| Jun 30, 2025 | -1.77 |
| Mar 31, 2025 | -4.38 |
| Dec 31, 2024 | -11.80 |
| Sep 30, 2024 | -10.96 |
| Jun 30, 2024 | -10.26 |
| Mar 31, 2024 | -47.30 |
| Dec 31, 2023 | -109.10 |
| Sep 30, 2023 | -90.18 |
| Jun 30, 2023 | -40.97 |
| Mar 31, 2023 | -136.19 |
| Dec 31, 2022 | -255.50 |
| Sep 30, 2022 | -45.25 |
| Jun 30, 2022 | -21.57 |
| Mar 31, 2022 | -24.01 |
| Dec 31, 2021 | -95.70 |
| Sep 30, 2021 | -9.78 |